Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Densem

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Prenatal Diagnosis|January 1, 1995
Down's syndrome screening: value of using free beta-hCGJ Densem, N J Wald
BMJ (Clinical Research Ed.)|October 24, 1992
Antenatal screening for Down's syndromeN Wald, J Densem, A Kennard
Prenatal Diagnosis|July 1, 1994
Repeat maternal serum testing in multiple marker Down's syndrome screening programmesH Cuckle, J Densem, N Wald
Lancet (London, England)|August 19, 1989
Maternal serum specific beta 1-glycoprotein in pregnancies associated with Down's syndromeN Wald, H Cuckle, J Densem
BMJ (Clinical Research Ed.)|August 3, 1991
Estimating risk of Down's syndromeH S Cuckle, N Wald, J Densem
British Journal of Obstetrics and Gynaecology|June 1, 1993
The use of free beta-hCG in antenatal screening for Down's syndromeN Wald, J Densem, R Stone, et al.
Prenatal Diagnosis|December 1, 1995
Repeat maternal serum testing for Down's syndrome screening using multiple markers with special reference to free alpha and free beta-hCGA K Hackshaw, J Densem, N J Wald
Prenatal Diagnosis|November 1, 1993
Serum alpha-fetoprotein and neural tube defects in the first trimester of pregnancy. MRC Vitamin Study Research GroupN J Wald, A Hackshaw, R Stone, et al.
British Journal of Obstetrics and Gynaecology|January 1, 1989
Repeat maternal serum alpha-fetoprotein testing in antenatal screening programmes for Down's syndromeH S Cuckle, N J Wald, K Nanchahal, et al.
Prenatal Diagnosis|August 1, 1996
Effect of allowing for ethnic group in prenatal screening for Down's syndromeH C Watt, N J Wald, D Smith, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Prenatal Diagnosis|January 1, 1995
Down's syndrome screening: value of using free beta-hCGJ Densem, N J Wald
BMJ (Clinical Research Ed.)|October 24, 1992
Antenatal screening for Down's syndromeN Wald, J Densem, A Kennard
Prenatal Diagnosis|July 1, 1994
Repeat maternal serum testing in multiple marker Down's syndrome screening programmesH Cuckle, J Densem, N Wald
Lancet (London, England)|August 19, 1989
Maternal serum specific beta 1-glycoprotein in pregnancies associated with Down's syndromeN Wald, H Cuckle, J Densem
BMJ (Clinical Research Ed.)|August 3, 1991
Estimating risk of Down's syndromeH S Cuckle, N Wald, J Densem
British Journal of Obstetrics and Gynaecology|June 1, 1993
The use of free beta-hCG in antenatal screening for Down's syndromeN Wald, J Densem, R Stone, et al.
Prenatal Diagnosis|December 1, 1995
Repeat maternal serum testing for Down's syndrome screening using multiple markers with special reference to free alpha and free beta-hCGA K Hackshaw, J Densem, N J Wald
Prenatal Diagnosis|November 1, 1993
Serum alpha-fetoprotein and neural tube defects in the first trimester of pregnancy. MRC Vitamin Study Research GroupN J Wald, A Hackshaw, R Stone, et al.
British Journal of Obstetrics and Gynaecology|January 1, 1989
Repeat maternal serum alpha-fetoprotein testing in antenatal screening programmes for Down's syndromeH S Cuckle, N J Wald, K Nanchahal, et al.
Prenatal Diagnosis|August 1, 1996
Effect of allowing for ethnic group in prenatal screening for Down's syndromeH C Watt, N J Wald, D Smith, et al.
Pageof 2